Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
After a split, the index divisor is adjusted to maintain continuity. This explanation covers the reasons and how it impacts index levels.
25,578 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Calumet (CLMT) has been a variable name in energy markets. This guide breaks down calumet (clmt) 2025 earnings, what ...
Losing a partner upends more than your personal life—it can reshape your income too. This guide walks you through the...
Rubrik faces a pivotal Q1 print, with traders watching for signs of margin expansion and cash flow improvement after ...
A growing number of high-earning savers say they’ve reached their retirement targets but can’t walk away from work. A...
Investors are re-evaluating JEPI after peers showed stronger upside. This report breaks down the real costs behind JE...
A landmark civil suit over ownership of long-dormant Bitcoin addresses has narrowed, with key defendants exiting as o...
A Life360 board director recently sold several thousand shares after exercising options, timing that coincides with a...
Shopify delivered strong quarterly results, but the stock traded lower as guidance softened. This article explains wh...
Could Tesla ride a $10 trillion wave of opportunity before 2029? This analysis breaks down the bets, the risks, and p...
When Valens Semiconductor released its first-quarter results, investors pushed valuations higher. This article breaks...
As AI workloads surge, terrestrial data centers face limits. This article identifies two stocks to buy before the arm...